This is a comparison between two groups of ovarian cancer patients. Patients in control group receive treatment with regular methods. Patients in comparison group receive the regular treatment methods and the DC-CIK cancer immunotherapy.

Each patient was followed for five years, and it came up with the list as below, it shows that patients who received cancer immunotherapy had more chances of cancer survival or cancer free rate.